STING1 and familial pancreatic carcinoma: It has also been suggested that biopolymers containing the combination of STING agonists and specific modified chimeric antigen receptor (CAR) T cells promote immune responses against tumor cells and significantly improve the overall survival of pancreatic cancer and melanoma mouse models (93).